Cargando…
After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study
INTRODUCTION: There is strong evidence that pharmacist care improves patients’ glycaemic control. However, the sustainability and durability of such interventions beyond the research period is not known. RxING was the first trial of pharmacist prescribing in diabetes and it showed an improvement in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538249/ https://www.ncbi.nlm.nih.gov/pubmed/26270946 http://dx.doi.org/10.1136/bmjopen-2015-008152 |